ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 107 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $60,000 | -62.5% | 83,600 | 0.0% | 0.00% | – |
| Q3 2018 | $160,000 | -68.9% | 83,600 | -8.1% | 0.00% | -100.0% |
| Q2 2018 | $515,000 | +23.8% | 91,000 | -7.5% | 0.00% | 0.0% |
| Q1 2018 | $416,000 | -20.9% | 98,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $526,000 | +19.8% | 98,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $439,000 | -8.2% | 98,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $478,000 | -32.9% | 98,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $712,000 | +21.3% | 98,400 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $587,000 | -55.4% | 102,700 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,315,000 | -3.9% | 102,700 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $1,368,000 | +36.8% | 109,800 | -8.2% | 0.00% | 0.0% |
| Q1 2016 | $1,000,000 | -16.0% | 119,600 | -0.5% | 0.00% | 0.0% |
| Q4 2015 | $1,190,000 | -22.9% | 120,200 | -4.5% | 0.00% | -33.3% |
| Q3 2015 | $1,544,000 | -22.6% | 125,900 | -3.2% | 0.00% | 0.0% |
| Q2 2015 | $1,994,000 | +1.1% | 130,000 | -4.4% | 0.00% | 0.0% |
| Q1 2015 | $1,972,000 | 0.0% | 136,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,972,000 | +36.8% | 136,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $1,442,000 | -28.3% | 136,000 | +2.9% | 0.00% | -33.3% |
| Q2 2014 | $2,011,000 | -8.6% | 132,200 | -23.6% | 0.00% | 0.0% |
| Q1 2014 | $2,200,000 | -22.9% | 173,100 | +4.3% | 0.00% | -25.0% |
| Q4 2013 | $2,855,000 | +9.3% | 166,000 | +2.5% | 0.00% | -20.0% |
| Q3 2013 | $2,613,000 | +92.3% | 162,000 | +58.4% | 0.01% | +66.7% |
| Q2 2013 | $1,359,000 | – | 102,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|